Ligand Pharmaceuticals Statistics

Total Valuation

LGND has a market cap or net worth of $1.25 billion. The enterprise value is $1.23 billion.

Market Cap	1.25B
Enterprise Value	1.23B

Important Dates

The next confirmed earnings date is Tuesday, May 7, 2024, after market close.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

LGND has 17.71 million shares outstanding. The number of shares has increased by 3.37% in one year.

Shares Outstanding	17.71M
Shares Change (YoY)	+3.37%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	5.93%
Owned by Institutions (%)	94.49%
Float	16.67M

Valuation Ratios

The trailing PE ratio is 23.29 and the forward PE ratio is 15.78. LGND's PEG ratio is 1.53.

PE Ratio	23.29
Forward PE	15.78
PS Ratio	n/a
Forward PS	8.92
PB Ratio	1.78
P/FCF Ratio	n/a
PEG Ratio	1.53

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.15, with a Debt / Equity ratio of 0.01.

Current Ratio	14.15
Quick Ratio	3.33
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	58
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.02% in the last 52 weeks. The beta is 0.92, so LGND's price volatility has been similar to the market average.

Beta (1Y)	0.92
52-Week Price Change	-9.02%
50-Day Moving Average	74.76
200-Day Moving Average	66.93
Relative Strength Index (RSI)	39.95
Average Volume (30 Days)	174,588

Short Selling Information

The latest short interest is 826,609, so 4.67% of the outstanding shares have been sold short.

Short Interest	826,609
Short Previous Month	672,084
Short % of Shares Out	4.67%
Short % of Float	4.96%
Short Ratio (days to cover)	3.10

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	$3.03

Full Income Statement

Balance Sheet

The company has $22.95 million in cash and $6.17 million in debt, giving a net cash position of $16.79 million or $0.95 per share.

Cash & Cash Equivalents	22.95M
Total Debt	6.17M
Net Cash	16.79M
Net Cash Per Share	$0.95
Equity / Book Value	700.91M
Book Value Per Share	39.59
Working Capital	220.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $49.58 million and capital expenditures -$53.43 million, giving a free cash flow of -$3.85 million.

Operating Cash Flow	49.58M
Capital Expenditures	-53.43M
Free Cash Flow	-3.85M
FCF Per Share	-$0.22

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LGND does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.37%
Shareholder Yield	-3.37%
Earnings Yield	n/a
FCF Yield	-0.31%

Dividend Details

Analyst Forecast

The average price target for LGND is $116.33, which is 64.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$116.33
Price Target Difference	64.84%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 2, 2022. It was a forward split with a ratio of 1603:1000.

Last Split Date	Nov 2, 2022
Split Type	Forward
Split Ratio	1603:1000

Scores

Altman Z-Score	n/a
Piotroski F-Score	3